GB9206412D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9206412D0
GB9206412D0 GB929206412A GB9206412A GB9206412D0 GB 9206412 D0 GB9206412 D0 GB 9206412D0 GB 929206412 A GB929206412 A GB 929206412A GB 9206412 A GB9206412 A GB 9206412A GB 9206412 D0 GB9206412 D0 GB 9206412D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929206412A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB929206412A priority Critical patent/GB9206412D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of GB9206412D0 publication Critical patent/GB9206412D0/en
Priority to PCT/GB1992/001094 priority patent/WO1993000080A1/en
Priority to DE69228813T priority patent/DE69228813T2/en
Priority to ES92912215T priority patent/ES2129448T3/en
Priority to DE1992628813 priority patent/DE122005000032I2/en
Priority to AT92912215T priority patent/ATE178207T1/en
Priority to EP92912215A priority patent/EP0591275B1/en
Priority to JP05501383A priority patent/JP3130935B2/en
Priority to DK92912215T priority patent/DK0591275T3/en
Priority to AU19860/92A priority patent/AU672361B2/en
Priority to CA002072047A priority patent/CA2072047C/en
Priority to PT100619A priority patent/PT100619B/en
Priority to IE202492A priority patent/IE922024A1/en
Priority to NO934798A priority patent/NO304923B1/en
Priority to US08/359,361 priority patent/US5550165A/en
Priority to HK98109412A priority patent/HK1008662A1/en
Priority to GR990400803T priority patent/GR3029841T3/en
Priority to NL300198C priority patent/NL300198I2/en
Priority to LU91180C priority patent/LU91180I2/en
Priority to NO2005018C priority patent/NO2005018I2/en
Priority to NO2017045C priority patent/NO2017045I1/en
Pending legal-status Critical Current

Links

GB929206412A 1991-06-24 1992-03-24 Pharmaceutical compositions Pending GB9206412D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB929206412A GB9206412D0 (en) 1992-03-24 1992-03-24 Pharmaceutical compositions
AU19860/92A AU672361B2 (en) 1991-06-24 1992-06-18 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
DE1992628813 DE122005000032I2 (en) 1991-06-24 1992-06-18 Use of 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione for the treatment of tyrosine and pharmaceutical compositions
DE69228813T DE69228813T2 (en) 1991-06-24 1992-06-18 USE OF 2- (2-NITRO-4-TRIFLUORMETHYLBENZOYL) -1,3-CYCLOHEXANDION FOR THE TREATMENT OF TYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS
ES92912215T ES2129448T3 (en) 1991-06-24 1992-06-18 USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS.
PCT/GB1992/001094 WO1993000080A1 (en) 1991-06-24 1992-06-18 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
AT92912215T ATE178207T1 (en) 1991-06-24 1992-06-18 USE OF 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDIONE FOR THE TREATMENT OF TYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS
EP92912215A EP0591275B1 (en) 1991-06-24 1992-06-18 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
JP05501383A JP3130935B2 (en) 1991-06-24 1992-06-18 Pharmaceutical composition
DK92912215T DK0591275T3 (en) 1991-06-24 1992-06-18 Use of 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione for the treatment of tyrosine anemia and pharmaceuticals together
CA002072047A CA2072047C (en) 1991-06-24 1992-06-23 Pharmaceutical compositions
PT100619A PT100619B (en) 1991-06-24 1992-06-24 PHARMACEUTICAL COMPOSITIONS
IE202492A IE922024A1 (en) 1991-06-24 1992-07-01 Pharmaceutical compositions
NO934798A NO304923B1 (en) 1991-06-24 1993-12-23 Pharmaceutical preparation containing 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione or a pharmaceutically acceptable salt thereof
US08/359,361 US5550165A (en) 1991-06-24 1994-12-19 Pharmaceutical compositions for the treatment of hereditary tyosinemia type I
HK98109412A HK1008662A1 (en) 1991-06-24 1998-07-27 Use of 2-(2-nitro-4- trifluoromethylbenzoyl)-1,3 yclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
GR990400803T GR3029841T3 (en) 1991-06-24 1999-04-01 Method of preparing a radioactive rhenium complex solution.
NL300198C NL300198I2 (en) 1991-06-24 2005-06-09 Use of 2- (2-nitro-4-trifluoromethylbenzoyl) cyclohexanedione-1,3 for the treatment of tyrosinaemia, as well as pharmaceutical preparations.
LU91180C LU91180I2 (en) 1991-06-24 2005-07-06 2- (2-Nirto-4trifluoromethylbenzoyl) -1,3-cyclohexanedione or one of its salts (in abbreviation "NTBC", common name nitisinone, brand name orfadin.
NO2005018C NO2005018I2 (en) 1991-06-24 2005-08-31 2- (2-Nitro-4-trifluoromethylbenzoyl) 1,3-cyclohexanedione or a salt thereof (Abbreviation: NTBC)
NO2017045C NO2017045I1 (en) 1991-06-24 2017-08-23 A pharmaceutical composition containing 2- (2-nitro-4-ifluoromethylbenzoyl) -1,3-cyclohexanedione or a pharmaceutically acceptable salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929206412A GB9206412D0 (en) 1992-03-24 1992-03-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9206412D0 true GB9206412D0 (en) 1992-05-06

Family

ID=10712748

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929206412A Pending GB9206412D0 (en) 1991-06-24 1992-03-24 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB9206412D0 (en)

Similar Documents

Publication Publication Date Title
GB9224855D0 (en) Pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
HUT66864A (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
ZA937592B (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
GB9211276D0 (en) Pharmaceutical compositions
ZA935931B (en) Pharmaceutical composition
ZA924061B (en) Pharmaceutical composition
ZA931984B (en) Pharmaceutical composition
ZA935161B (en) Pharmaceutical compositions
GB9321452D0 (en) Pharmaceutical compositions
GB9221800D0 (en) Pharmaceutical compositions
GB9222942D0 (en) Pharmaceutical compositions
GB9221447D0 (en) Pharmaceutical compositions
GB9211400D0 (en) Pharmaceutical compositions
GB9210226D0 (en) Pharmaceutical compositions
IL102579A0 (en) Pharmaceutical compositions
GB9206412D0 (en) Pharmaceutical compositions
GB9203500D0 (en) Pharmaceutical compositions
ZA925331B (en) Pharmaceutical compositions